| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | integrin binding | 1.13e-06 | 175 | 155 | 10 | GO:0005178 | |
| GeneOntologyMolecularFunction | nuclear receptor activity | 7.03e-06 | 60 | 155 | 6 | GO:0004879 | |
| GeneOntologyMolecularFunction | ligand-activated transcription factor activity | 7.75e-06 | 61 | 155 | 6 | GO:0098531 | |
| GeneOntologyMolecularFunction | ethanol binding | 9.02e-06 | 6 | 155 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine 6-O-sulfotransferase activity | 1.57e-05 | 7 | 155 | 3 | GO:0001517 | |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 5.99e-05 | 2 | 155 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | TES VWF SWAP70 TNC ADAM18 ICAM2 TBC1D2 ITGA8 ADAMTS8 DBN1 SVEP1 ITGBL1 FBN1 PI4KA CCN2 | 6.83e-05 | 599 | 155 | 15 | GO:0050839 |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGC4 SWAP70 PCDHGB5 ITLN1 RET F2 LDLR SVEP1 STAB1 FBN1 FBN2 PROZ EGF SLIT1 PCDHGB4 LRP2 ASTN2 | 7.45e-05 | 749 | 155 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | zinc ion binding | TES ADAMTS4 KDM5C RNF144A MYT1 ADAMTS8 PGR ADH1A ADH1B ADH1C ALKBH8 NR2E1 NR5A2 RORB NR3C2 TRIM40 ERVK-24 NR1H4 | 1.96e-04 | 891 | 155 | 18 | GO:0008270 |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 2.39e-04 | 16 | 155 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | keratan sulfotransferase activity | 3.56e-04 | 4 | 155 | 2 | GO:0045130 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 5.51e-04 | 21 | 155 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 8.24e-04 | 24 | 155 | 3 | GO:0004745 | |
| GeneOntologyMolecularFunction | nuclear steroid receptor activity | 9.31e-04 | 25 | 155 | 3 | GO:0003707 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 1.05e-03 | 26 | 155 | 3 | GO:0004022 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 4.16e-07 | 3 | 155 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 4.12e-06 | 5 | 155 | 3 | GO:0006117 | |
| GeneOntologyCellularComponent | extracellular matrix | PODNL1 VWC2 VWF PSAP ADAMTS4 TNC ITLN1 LAMA2 LAMC2 ADAMTS8 F2 CBLN1 SVEP1 CBLN4 FBN1 FBN2 ADAMTS6 CLEC14A CCN2 OTOG | 7.21e-08 | 656 | 153 | 20 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | PODNL1 VWC2 VWF PSAP ADAMTS4 TNC ITLN1 LAMA2 LAMC2 ADAMTS8 F2 CBLN1 SVEP1 CBLN4 FBN1 FBN2 ADAMTS6 CLEC14A CCN2 OTOG | 7.57e-08 | 658 | 153 | 20 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | PODNL1 VWC2 VWF PSAP ADAMTS4 TNC ITLN1 LAMA2 LAMC2 ADAMTS8 F2 CBLN1 CBLN4 FBN1 FBN2 CLEC14A CCN2 | 3.67e-07 | 530 | 153 | 17 | GO:0062023 |
| GeneOntologyCellularComponent | synaptic cleft | 9.57e-05 | 33 | 153 | 4 | GO:0043083 | |
| MousePheno | abnormal ethanol metabolism | 1.30e-05 | 6 | 123 | 3 | MP:0005443 | |
| MousePheno | abnormal aggression-related behavior | 1.60e-05 | 127 | 123 | 8 | MP:0002061 | |
| MousePheno | abnormal retinol metabolism | 2.27e-05 | 7 | 123 | 3 | MP:0005444 | |
| Domain | EGF-like_dom | TNC ADAM18 LAMA2 LAMC2 LDLR SVEP1 STAB1 ITGBL1 FBN1 FBN2 PROZ EGF CLEC14A SLIT1 LRP2 OTOG | 2.56e-10 | 249 | 154 | 16 | IPR000742 |
| Domain | EGF_1 | TNC ADAM18 LAMA2 LAMC2 LDLR SVEP1 STAB1 ITGBL1 FBN1 FBN2 PROZ EGF CLEC14A SLIT1 LRP2 ASTN2 | 3.63e-10 | 255 | 154 | 16 | PS00022 |
| Domain | EGF_2 | TNC ADAM18 LAMA2 LAMC2 LDLR SVEP1 STAB1 ITGBL1 FBN1 FBN2 PROZ EGF CLEC14A SLIT1 LRP2 ASTN2 | 6.38e-10 | 265 | 154 | 16 | PS01186 |
| Domain | Growth_fac_rcpt_ | TNC LAMC2 HTRA3 LDLR SVEP1 STAB1 FBN1 FBN2 EGF SLIT1 LRP2 CCN2 | 6.50e-09 | 156 | 154 | 12 | IPR009030 |
| Domain | EGF | TNC LAMA2 LAMC2 LDLR SVEP1 STAB1 ITGBL1 FBN1 FBN2 PROZ EGF CLEC14A SLIT1 LRP2 | 9.38e-09 | 235 | 154 | 14 | SM00181 |
| Domain | EGF_3 | TNC ADAM18 LDLR SVEP1 STAB1 FBN1 FBN2 PROZ EGF CLEC14A SLIT1 LRP2 ASTN2 OTOG | 9.38e-09 | 235 | 154 | 14 | PS50026 |
| Domain | EGF-like_CS | TNC ADAM18 LAMA2 LAMC2 LDLR SVEP1 STAB1 FBN1 FBN2 PROZ EGF CLEC14A SLIT1 LRP2 | 3.53e-08 | 261 | 154 | 14 | IPR013032 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.31e-07 | 106 | 154 | 9 | IPR000152 | |
| Domain | EGF_CA | 7.69e-07 | 122 | 154 | 9 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 8.82e-07 | 124 | 154 | 9 | IPR001881 | |
| Domain | Cys_knot_C | 1.66e-06 | 25 | 154 | 5 | IPR006207 | |
| Domain | CTCK_2 | 1.66e-06 | 25 | 154 | 5 | PS01225 | |
| Domain | ASX_HYDROXYL | 1.74e-06 | 100 | 154 | 8 | PS00010 | |
| Domain | Znf_hrmn_rcpt | 2.03e-06 | 46 | 154 | 6 | IPR001628 | |
| Domain | NUCLEAR_REC_DBD_2 | 2.03e-06 | 46 | 154 | 6 | PS51030 | |
| Domain | NUCLEAR_REC_DBD_1 | 2.03e-06 | 46 | 154 | 6 | PS00031 | |
| Domain | ZnF_C4 | 2.03e-06 | 46 | 154 | 6 | SM00399 | |
| Domain | zf-C4 | 2.03e-06 | 46 | 154 | 6 | PF00105 | |
| Domain | Nucl_hrmn_rcpt_lig-bd | 2.63e-06 | 48 | 154 | 6 | IPR000536 | |
| Domain | HOLI | 2.63e-06 | 48 | 154 | 6 | SM00430 | |
| Domain | Hormone_recep | 2.63e-06 | 48 | 154 | 6 | PF00104 | |
| Domain | Znf_NHR/GATA | 8.10e-06 | 58 | 154 | 6 | IPR013088 | |
| Domain | EGF_extracell | 9.88e-06 | 60 | 154 | 6 | IPR013111 | |
| Domain | EGF_2 | 9.88e-06 | 60 | 154 | 6 | PF07974 | |
| Domain | CTCK_1 | 1.24e-05 | 18 | 154 | 4 | PS01185 | |
| Domain | EGF_Ca-bd_CS | 1.56e-05 | 97 | 154 | 7 | IPR018097 | |
| Domain | EGF_CA | 1.78e-05 | 99 | 154 | 7 | PS01187 | |
| Domain | Carbohydrate_sulfotransferase | 1.88e-05 | 7 | 154 | 3 | IPR016469 | |
| Domain | CT | 2.90e-05 | 22 | 154 | 4 | SM00041 | |
| Domain | ADH_Zn_CS | 2.99e-05 | 8 | 154 | 3 | IPR002328 | |
| Domain | ADH_ZINC | 2.99e-05 | 8 | 154 | 3 | PS00059 | |
| Domain | Nuclear_hrmn_rcpt | 3.73e-05 | 46 | 154 | 5 | IPR001723 | |
| Domain | - | 4.14e-05 | 47 | 154 | 5 | 1.10.565.10 | |
| Domain | RabGDI | 6.75e-05 | 2 | 154 | 2 | IPR000806 | |
| Domain | EGF_CA | 7.78e-05 | 86 | 154 | 6 | PF07645 | |
| Domain | EGF | 8.41e-05 | 126 | 154 | 7 | PF00008 | |
| Domain | GFP-like | 8.64e-05 | 11 | 154 | 3 | IPR023413 | |
| Domain | - | 8.64e-05 | 11 | 154 | 3 | 2.40.155.10 | |
| Domain | - | 1.06e-04 | 57 | 154 | 5 | 3.30.50.10 | |
| Domain | VitD_rcpt | 1.87e-04 | 14 | 154 | 3 | IPR000324 | |
| Domain | TIL_dom | 1.87e-04 | 14 | 154 | 3 | IPR002919 | |
| Domain | Ldl_recept_b | 1.87e-04 | 14 | 154 | 3 | PF00058 | |
| Domain | LDLRB | 1.87e-04 | 14 | 154 | 3 | PS51120 | |
| Domain | FBN | 2.02e-04 | 3 | 154 | 2 | IPR011398 | |
| Domain | LY | 2.33e-04 | 15 | 154 | 3 | SM00135 | |
| Domain | LDLR_classB_rpt | 2.33e-04 | 15 | 154 | 3 | IPR000033 | |
| Domain | PKS_ER | 2.85e-04 | 16 | 154 | 3 | IPR020843 | |
| Domain | ADH_N | 2.85e-04 | 16 | 154 | 3 | PF08240 | |
| Domain | PKS_ER | 2.85e-04 | 16 | 154 | 3 | SM00829 | |
| Domain | ADH_N | 2.85e-04 | 16 | 154 | 3 | IPR013154 | |
| Domain | Pep_M12B_propep | 2.92e-04 | 39 | 154 | 4 | PF01562 | |
| Domain | Peptidase_M12B_N | 2.92e-04 | 39 | 154 | 4 | IPR002870 | |
| Domain | DISINTEGRIN_1 | 3.22e-04 | 40 | 154 | 4 | PS00427 | |
| Domain | Reprolysin | 3.22e-04 | 40 | 154 | 4 | PF01421 | |
| Domain | ADAM_MEPRO | 3.22e-04 | 40 | 154 | 4 | PS50215 | |
| Domain | DISINTEGRIN_2 | 3.22e-04 | 40 | 154 | 4 | PS50214 | |
| Domain | Peptidase_M12B | 3.22e-04 | 40 | 154 | 4 | IPR001590 | |
| Domain | Disintegrin_dom | 3.55e-04 | 41 | 154 | 4 | IPR001762 | |
| Domain | VWF_dom | 3.90e-04 | 42 | 154 | 4 | IPR001007 | |
| Domain | GDI | 4.01e-04 | 4 | 154 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 4.01e-04 | 4 | 154 | 2 | IPR018203 | |
| Domain | - | 4.10e-04 | 18 | 154 | 3 | 3.90.180.10 | |
| Domain | Leu-rich_rpt_Cys-con_subtyp | 4.83e-04 | 19 | 154 | 3 | IPR006553 | |
| Domain | LRR_CC | 4.83e-04 | 19 | 154 | 3 | SM00367 | |
| Domain | ADH_zinc_N | 4.83e-04 | 19 | 154 | 3 | PF00107 | |
| Domain | ADH_SF_Zn-type | 4.83e-04 | 19 | 154 | 3 | IPR002085 | |
| Domain | ADH_C | 4.83e-04 | 19 | 154 | 3 | IPR013149 | |
| Domain | PH | 5.09e-04 | 278 | 154 | 9 | SM00233 | |
| Domain | PH_DOMAIN | 5.23e-04 | 279 | 154 | 9 | PS50003 | |
| Domain | PH_domain | 5.36e-04 | 280 | 154 | 9 | IPR001849 | |
| Domain | PH | 6.36e-04 | 229 | 154 | 8 | PF00169 | |
| Domain | SapB_2 | 6.65e-04 | 5 | 154 | 2 | PF03489 | |
| Domain | SapB_2 | 6.65e-04 | 5 | 154 | 2 | IPR008138 | |
| Domain | Spectrin | 8.63e-04 | 23 | 154 | 3 | PF00435 | |
| Domain | ACTININ_2 | 8.63e-04 | 23 | 154 | 3 | PS00020 | |
| Domain | ACTININ_1 | 8.63e-04 | 23 | 154 | 3 | PS00019 | |
| Domain | ADAM_spacer1 | 8.63e-04 | 23 | 154 | 3 | IPR010294 | |
| Domain | Actinin_actin-bd_CS | 8.63e-04 | 23 | 154 | 3 | IPR001589 | |
| Domain | ADAM_spacer1 | 8.63e-04 | 23 | 154 | 3 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 9.80e-04 | 24 | 154 | 3 | IPR013273 | |
| Domain | GroES-like | 9.80e-04 | 24 | 154 | 3 | IPR011032 | |
| Domain | SapB | 9.91e-04 | 6 | 154 | 2 | SM00741 | |
| Domain | - | 1.17e-03 | 56 | 154 | 4 | 3.50.50.60 | |
| Domain | cEGF | 1.24e-03 | 26 | 154 | 3 | PF12662 | |
| Domain | cEGF | 1.24e-03 | 26 | 154 | 3 | IPR026823 | |
| Domain | FAD/NAD-binding_dom | 1.25e-03 | 57 | 154 | 4 | IPR023753 | |
| Domain | TB | 1.38e-03 | 7 | 154 | 2 | PF00683 | |
| Domain | SaposinB_dom | 1.38e-03 | 7 | 154 | 2 | IPR008139 | |
| Domain | ADAM_Cys-rich | 1.39e-03 | 27 | 154 | 3 | IPR006586 | |
| Domain | ACR | 1.39e-03 | 27 | 154 | 3 | SM00608 | |
| Domain | hEGF | 1.55e-03 | 28 | 154 | 3 | PF12661 | |
| Domain | VWC | 1.55e-03 | 28 | 154 | 3 | PF00093 | |
| Domain | Spectrin_repeat | 1.72e-03 | 29 | 154 | 3 | IPR002017 | |
| Domain | TSP_1 | 1.81e-03 | 63 | 154 | 4 | PF00090 | |
| Domain | Saposin-like | 1.83e-03 | 8 | 154 | 2 | IPR011001 | |
| Domain | - | 1.83e-03 | 8 | 154 | 2 | 3.90.290.10 | |
| Domain | - | 1.83e-03 | 8 | 154 | 2 | 1.10.225.10 | |
| Domain | AlkB-like | 1.83e-03 | 8 | 154 | 2 | IPR027450 | |
| Domain | LAMININ_IVA | 1.83e-03 | 8 | 154 | 2 | PS51115 | |
| Domain | Laminin_B | 1.83e-03 | 8 | 154 | 2 | PF00052 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 1.95e-06 | 48 | 111 | 6 | MM14987 | |
| Pathway | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | 3.53e-06 | 53 | 111 | 6 | M8276 | |
| Pathway | REACTOME_ABACAVIR_ADME | 2.59e-05 | 8 | 111 | 3 | MM14869 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 5.48e-05 | 10 | 111 | 3 | MM15833 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 6.44e-05 | 28 | 111 | 4 | MM15042 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 7.49e-05 | 11 | 111 | 3 | MM15405 | |
| Pathway | REACTOME_SUMOYLATION_OF_INTRACELLULAR_RECEPTORS | 8.52e-05 | 30 | 111 | 4 | M27323 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 9.93e-05 | 12 | 111 | 3 | M14663 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.27e-04 | 300 | 111 | 10 | M610 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 1.69e-04 | 66 | 111 | 5 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 1.75e-04 | 199 | 111 | 8 | M39402 | |
| Pathway | KEGG_FOCAL_ADHESION | 1.75e-04 | 199 | 111 | 8 | M7253 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.02e-04 | 15 | 111 | 3 | M39717 | |
| Pathway | WP_COMPREHENSIVE_IL17A_SIGNALING | 2.29e-04 | 110 | 111 | 6 | MM16642 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 3.24e-04 | 42 | 111 | 4 | M16743 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 3.27e-04 | 76 | 111 | 5 | MM14867 | |
| Pathway | BIOCARTA_MPR_PATHWAY | 3.56e-04 | 18 | 111 | 3 | MM1407 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 5.21e-04 | 84 | 111 | 5 | M7098 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 5.50e-04 | 85 | 111 | 5 | M16441 | |
| Pathway | BIOCARTA_MPR_PATHWAY | 5.70e-04 | 21 | 111 | 3 | M13883 | |
| Pathway | WP_FOCAL_ADHESION | 6.87e-04 | 187 | 111 | 7 | MM15913 | |
| Pubmed | 8.41e-08 | 118 | 161 | 8 | 16971476 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 11960985 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2474823 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2737681 | ||
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 9.74e-08 | 3 | 161 | 3 | 23772048 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 9.74e-08 | 3 | 161 | 3 | 24787690 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 3011597 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 6756216 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 37806378 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 7840644 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 23853053 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 9.74e-08 | 3 | 161 | 3 | 15670660 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 9.74e-08 | 3 | 161 | 3 | 33586683 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 29691328 | ||
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 9.74e-08 | 3 | 161 | 3 | 3157987 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2169444 | ||
| Pubmed | Cerebellins are differentially expressed in selective subsets of neurons throughout the brain. | 9.74e-08 | 3 | 161 | 3 | 28714144 | |
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 9.74e-08 | 3 | 161 | 3 | 8486690 | |
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 9.74e-08 | 3 | 161 | 3 | 16801720 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 9.74e-08 | 3 | 161 | 3 | 10424757 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2347582 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 9.74e-08 | 3 | 161 | 3 | 7748347 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 3006456 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 9.74e-08 | 3 | 161 | 3 | 9145544 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 9.74e-08 | 3 | 161 | 3 | 6816803 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 9.74e-08 | 3 | 161 | 3 | 15554233 | |
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 35354963 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 6370228 | ||
| Pubmed | 9.74e-08 | 3 | 161 | 3 | 2935875 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 17606262 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 8813054 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 17331201 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 21410790 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 12631290 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 2893758 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 11893554 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 29663519 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 12851412 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 9733106 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 36224745 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 9202249 | ||
| Pubmed | Distinct expression of Cbln family mRNAs in developing and adult mouse brains. | 3.88e-07 | 4 | 161 | 3 | 16930405 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 19618839 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 3.88e-07 | 4 | 161 | 3 | 3996732 | |
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 9241435 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 10880953 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 9002638 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 22191730 | ||
| Pubmed | 3.88e-07 | 4 | 161 | 3 | 15193143 | ||
| Pubmed | Cbln1 is essential for interaction-dependent secretion of Cbln3. | 3.88e-07 | 4 | 161 | 3 | 17030622 | |
| Pubmed | 4.27e-07 | 14 | 161 | 4 | 36347239 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 11836246 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 8621625 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 36205393 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 1316195 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 7738026 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 8892527 | ||
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 7026729 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 9.67e-07 | 5 | 161 | 3 | 19193628 | |
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 9.67e-07 | 5 | 161 | 3 | 22079585 | |
| Pubmed | 9.67e-07 | 5 | 161 | 3 | 10358022 | ||
| Pubmed | 1.00e-06 | 17 | 161 | 4 | 20856818 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 17257171 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 26807981 | ||
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 12027900 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 1.93e-06 | 6 | 161 | 3 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 1.93e-06 | 6 | 161 | 3 | 9982 | |
| Pubmed | 1.93e-06 | 6 | 161 | 3 | 518534 | ||
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 1.93e-06 | 6 | 161 | 3 | 17185388 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 2.57e-06 | 248 | 161 | 9 | 24006456 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 16685648 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 3.36e-06 | 7 | 161 | 3 | 23468174 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 36823038 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 16047160 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 11784316 | ||
| Pubmed | Androgen regulation of gene expression in primary epithelial cells of the mouse kidney. | 3.36e-06 | 7 | 161 | 3 | 8119157 | |
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 37953328 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 29782851 | ||
| Pubmed | 3.36e-06 | 7 | 161 | 3 | 11181564 | ||
| Pubmed | 4.79e-06 | 53 | 161 | 5 | 15306695 | ||
| Pubmed | Putative functions of extracellular matrix glycoproteins in secondary palate morphogenesis. | 5.36e-06 | 8 | 161 | 3 | 23055981 | |
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 7937138 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 18331377 | ||
| Pubmed | 5.36e-06 | 8 | 161 | 3 | 2040456 | ||
| Pubmed | 7.69e-06 | 153 | 161 | 7 | 25037231 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 7.90e-06 | 101 | 161 | 6 | 23382219 | |
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 21356198 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 12122015 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 93520 | ||
| Pubmed | 8.01e-06 | 9 | 161 | 3 | 11747070 | ||
| Pubmed | 1.10e-05 | 30 | 161 | 4 | 6375655 | ||
| Pubmed | Celastrol recruits UBE3A to recognize and degrade the DNA binding domain of steroid receptors. | 1.14e-05 | 10 | 161 | 3 | 36109631 | |
| Pubmed | Sulfation of the human immunodeficiency virus envelope glycoprotein. | 1.14e-05 | 10 | 161 | 3 | 1433500 | |
| Pubmed | TBX1 is required for normal stria vascularis and semicircular canal development. | 1.26e-05 | 31 | 161 | 4 | 31550482 | |
| Interaction | CBLN3 interactions | 1.74e-06 | 4 | 154 | 3 | int:CBLN3 | |
| Interaction | DAGLB interactions | 5.83e-06 | 59 | 154 | 6 | int:DAGLB | |
| Cytoband | 4q23 | 4.62e-05 | 20 | 161 | 3 | 4q23 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 3.01e-04 | 37 | 161 | 3 | chr4q23 | |
| GeneFamily | Nuclear hormone receptors | 5.00e-07 | 49 | 110 | 6 | 71 | |
| GeneFamily | Alcohol dehydrogenases | 1.20e-05 | 8 | 110 | 3 | 397 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 1.98e-04 | 19 | 110 | 3 | 50 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 1.14e-03 | 34 | 110 | 3 | 487 | |
| GeneFamily | MCM family | 1.28e-03 | 9 | 110 | 2 | 1085 | |
| GeneFamily | Alkylation repair homologs | 1.28e-03 | 9 | 110 | 2 | 401 | |
| GeneFamily | Sulfotransferases, membrane bound | 1.46e-03 | 37 | 110 | 3 | 763 | |
| GeneFamily | PHD finger proteins | 2.22e-03 | 90 | 110 | 4 | 88 | |
| GeneFamily | Laminin subunits | 2.33e-03 | 12 | 110 | 2 | 626 | |
| GeneFamily | Gla domain containing | 2.74e-03 | 13 | 110 | 2 | 1250 | |
| GeneFamily | Low density lipoprotein receptors | 2.74e-03 | 13 | 110 | 2 | 634 | |
| Coexpression | NABA_MATRISOME | PODNL1 VWC2 VWF ADAMTS4 TNC ADAM18 ITLN1 LAMA2 LAMC2 HTRA3 ADAMTS8 F2 CBLN1 SVEP1 CBLN4 FBN1 FBN2 IL1F10 EGF ADAMTS6 CLEC14A CBLN2 SLIT1 CCN2 OTOG | 1.92e-09 | 1008 | 158 | 25 | MM17056 |
| Coexpression | NABA_MATRISOME | PODNL1 VWC2 VWF ADAMTS4 TNC ADAM18 ITLN1 LAMA2 LAMC2 HTRA3 ADAMTS8 F2 CBLN1 SVEP1 CBLN4 FBN1 FBN2 IL1F10 EGF ADAMTS6 CLEC14A CBLN2 SLIT1 CCN2 OTOG | 2.75e-09 | 1026 | 158 | 25 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.62e-07 | 191 | 158 | 10 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 3.33e-07 | 196 | 158 | 10 | M3008 | |
| Coexpression | NABA_CORE_MATRISOME | 7.99e-07 | 270 | 158 | 11 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 9.57e-07 | 275 | 158 | 11 | M5884 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 4.51e-06 | 109 | 158 | 7 | MM1214 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 4.73e-05 | 213 | 158 | 8 | M12176 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_FIBROBLAST_CELL | 6.38e-05 | 164 | 158 | 7 | M41676 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LIVER_METASTASIS | 7.45e-05 | 14 | 158 | 3 | M48002 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | FLNC TNC POLH RNF144A LAMA2 ITGA8 SOSTDC1 ACVR1C CBLN1 SVEP1 FBN1 FBN2 SYNE2 | 4.76e-07 | 310 | 155 | 13 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | FLNC CACNA2D2 TNC POLH RNF144A LAMA2 ITGA8 SOSTDC1 RAD9B CHST1 ACVR1C CBLN1 SVEP1 ADH1C CBLN4 FBN1 FBN2 SPACA1 SYNE2 | 3.46e-06 | 768 | 155 | 19 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_DevVasTestis_Flk_top-relative-expression-ranked_1000 | TES SH2B3 SWAP70 RNF144A ICAM2 FBXL17 DGKH CHST1 DBN1 CBLN1 LRCH1 STAB1 ADH1C FAM171A1 ASAP2 FBXL7 CLEC14A NR5A2 PGM2 | 1.39e-05 | 847 | 155 | 19 | gudmap_dev gonad_e12.5_M_gudmap_devVasTestis_Flk_1000 |
| ToppCell | E17.5-Mesenchymal-developing_mesenchymal_cell-mesenchymal_immature_unknown_1|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | PODNL1 VWF ICAM2 ZYX SVEP1 ADH1C FAM171A1 FBN1 CLEC14A ASTN2 PRR14L | 2.88e-11 | 170 | 159 | 11 | 7fa022471e14ac8a3bc147c793368a4d56a8e591 |
| ToppCell | COPD-Stromal-Myofibroblast|COPD / Disease state, Lineage and Cell class | ADAMTS4 TNC LAMA2 ITGA8 HTRA3 ADAMTS8 SVEP1 ADH1B ITGBL1 FBXL7 CCN2 | 1.33e-10 | 196 | 159 | 11 | af206bb5bbb8b604a6212acd79878bcc3d326cec |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TNC RNF144A LAMA2 ITGA8 ABCC9 SVEP1 PGR ADH1B FBN1 FBXL7 CCN2 | 1.33e-10 | 196 | 159 | 11 | ba869f7a86f37fd6d84d6ad69baca0e0faaf5887 |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | TNC RNF144A LAMA2 ITGA8 ABCC9 SVEP1 PGR ADH1B FBN1 FBXL7 CCN2 | 1.33e-10 | 196 | 159 | 11 | 30ad56d49000e4ddce73b4443b3994564bd1e2d6 |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-Myofibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | FMO3 TNC LAMA2 ITGA8 HTRA3 ADAMTS8 SVEP1 ADH1B ITGBL1 FBN1 CCN2 | 1.57e-10 | 199 | 159 | 11 | 7a227c239afdaebcac84644d9b2653a5f1a4be71 |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-09 | 189 | 159 | 10 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-09 | 189 | 159 | 10 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | LAMA2 ITGA8 PARD3B ADAMTS8 SVEP1 ADH1B ITGBL1 FBN1 FBXL7 CCN2 | 1.85e-09 | 191 | 159 | 10 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-09 | 193 | 159 | 10 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-09 | 194 | 159 | 10 | 240d122dcb9dd1ab2867503ad85869853adcacae | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.15e-09 | 194 | 159 | 10 | ae7df037592f1c20c9d32be15fe6fc3c562ebeb1 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-09 | 195 | 159 | 10 | cad6563cc51d212554152c727fc2c249c6a07e4d | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-09 | 195 | 159 | 10 | 783bfa8110161cbd6def50ce849cae676c39c458 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-09 | 195 | 159 | 10 | d8ebb94f30d4a655d6b29dd6a3076be2403d2356 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.26e-09 | 195 | 159 | 10 | 44d7bef5f59c2c2bad1392ee6aabdaa5d7f531d9 | |
| ToppCell | COPD-Stromal|COPD / Disease state, Lineage and Cell class | ADAMTS4 LAMA2 ITGA8 HTRA3 ADAMTS8 SVEP1 ADH1B FBN1 FBXL7 CCN2 | 2.49e-09 | 197 | 159 | 10 | d5390d86acaa8c39f1da893e8d2271f9ed2951d7 |
| ToppCell | COPD-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | ADAMTS4 TNC LAMA2 ITGA8 ADAMTS8 SVEP1 ADH1B ITGBL1 FBXL7 CCN2 | 2.49e-09 | 197 | 159 | 10 | d51f484b4e01ac64233950d0b97fa88825ea1dbb |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.49e-09 | 197 | 159 | 10 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | tumor_Lung-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lung / Location, Cell class and cell subclass | 2.62e-09 | 198 | 159 | 10 | 2d7842f352273b6b823c86eb548b9f4a4cddf0ae | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | PODNL1 FMO3 LAMA2 ITGA8 HTRA3 ADAMTS8 SVEP1 ADH1B ITGBL1 FBN1 | 2.62e-09 | 198 | 159 | 10 | 300d7cc56207d77168390fa1ffcbcf76767b1b80 |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | PODNL1 LAMA2 ITGA8 HTRA3 ADAMTS8 SVEP1 ADH1B ITGBL1 FBN1 CCN2 | 2.89e-09 | 200 | 159 | 10 | e504570fd7eec1524c401b1cfa9d10822d80d994 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.02e-09 | 166 | 159 | 9 | ec719368295133da2f7ff587c5329ed6db1dd56d | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 1.05e-08 | 169 | 159 | 9 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-08 | 172 | 159 | 9 | ab1c81be29f93ca8920c6ab5ab92f497a9256d3f | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-08 | 172 | 159 | 9 | 1ef243bce63d841c25e4b74d029d1377f84bcc3d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-08 | 181 | 159 | 9 | 3462aa1c08fbaf613b6278ab2c7a5a0940bf537d | |
| ToppCell | PND14-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-08 | 181 | 159 | 9 | 6730e249cac55ae892cc567d9211615882f3dab4 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.42e-08 | 186 | 159 | 9 | 5473283fb95cee556b1f6934cf72169b676b5bcc | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 2.54e-08 | 187 | 159 | 9 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.66e-08 | 188 | 159 | 9 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-08 | 190 | 159 | 9 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-08 | 191 | 159 | 9 | cd497abed9e00e4e0becd9dbc036c6e7a60ae791 | |
| ToppCell | ASK454-Mesenchymal|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.05e-08 | 191 | 159 | 9 | e30ae7a12439f8a79820b13f03e822c1223fd0cb | |
| ToppCell | Endothelial-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | VWF ADAMTS4 HSPA12B CBLN1 FAM171A1 FBN1 ADAMTS6 CLEC14A NR5A2 | 3.05e-08 | 191 | 159 | 9 | f702dfe88a9b04091dae87df61b2b4f43525f86a |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.05e-08 | 191 | 159 | 9 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | ASK440-Mesenchymal|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.05e-08 | 191 | 159 | 9 | f12959eebb4167e1aa03de05d7711a702c58b3c9 | |
| ToppCell | ASK454-Mesenchymal-Fibroblast|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.05e-08 | 191 | 159 | 9 | 1726add3f392a061536b7aff72ba84303f4a0b1f | |
| ToppCell | ASK440-Mesenchymal-Fibroblast|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.05e-08 | 191 | 159 | 9 | 387296b5377ef6839f0812e5b3529a10b5f7d530 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-08 | 192 | 159 | 9 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-08 | 192 | 159 | 9 | 5105e4b577408b4e1a62d0a44c23c2b830ccad88 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-08 | 192 | 159 | 9 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-08 | 192 | 159 | 9 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-08 | 192 | 159 | 9 | d3c1ad4667a1e223a83ca0fcd5991a0b96f1199a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.19e-08 | 192 | 159 | 9 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.19e-08 | 192 | 159 | 9 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-08 | 193 | 159 | 9 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.33e-08 | 193 | 159 | 9 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.33e-08 | 193 | 159 | 9 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.33e-08 | 193 | 159 | 9 | e09387af84d2a0a526e54d4793e6e06c6739db53 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-08 | 194 | 159 | 9 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.48e-08 | 194 | 159 | 9 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 3.64e-08 | 195 | 159 | 9 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.64e-08 | 195 | 159 | 9 | d9a5c75d31c6e8bb1e1ab7fd115ac5deb5fb1c8d | |
| ToppCell | IPF-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.81e-08 | 196 | 159 | 9 | 7fc9894ceb79dab9f0495acc84e2d6d0d1c69bb7 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-08 | 196 | 159 | 9 | a12dd986df65c36f248cf10815c3b8b6238613b0 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-08 | 196 | 159 | 9 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.81e-08 | 196 | 159 | 9 | 3e6803587d8566fd08cb8b290be3b6461743d79c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.81e-08 | 196 | 159 | 9 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-08 | 197 | 159 | 9 | b349f8e96d61a4c296af64711e11fc44459a9413 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.98e-08 | 197 | 159 | 9 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-G|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.98e-08 | 197 | 159 | 9 | a21a710c824f9e5c7ef1674168d1ce5aef85bd35 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.98e-08 | 197 | 159 | 9 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-08 | 197 | 159 | 9 | 6d027119a5f7ca2aac1b10837e43f9a2bb54db85 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-08 | 197 | 159 | 9 | 4cf4e9553397cd8dee883dbec24f41bec41aff99 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.98e-08 | 197 | 159 | 9 | c2e390653d5dee7e731c1840cfdab41987dede9b | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.15e-08 | 198 | 159 | 9 | 79576525a10ed3e3a9d1608077cd16ecda23376f | |
| ToppCell | COPD-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 4.15e-08 | 198 | 159 | 9 | 2f13c0b3372af53d1bd85f9546f315c878580a71 | |
| ToppCell | distal-1-mesenchymal-Alveolar_Fibroblast|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.15e-08 | 198 | 159 | 9 | 6594c35ab203dc51462167c61807b0d49fa30fb2 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-08 | 198 | 159 | 9 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.15e-08 | 198 | 159 | 9 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | distal-mesenchymal-Alveolar_Fibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.34e-08 | 199 | 159 | 9 | 28c1722deef3b8347371c7359be7c64b95780de3 | |
| ToppCell | Fibroblasts|World / lung cells shred on cell class, cell subclass, sample id | 4.34e-08 | 199 | 159 | 9 | e2b6752fcabd5249a166486ae6796f2c97c1fcaf | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G-|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-08 | 199 | 159 | 9 | 9c6d1c328bfbb6547f4c7bb2a784576a56bd72af | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.34e-08 | 199 | 159 | 9 | 66a79732caf2f04c09b4d9832377aa01ca477677 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-G|343B / Donor, Lineage, Cell class and subclass (all cells) | 4.34e-08 | 199 | 159 | 9 | f4b6c095cbe7a38b310adc49be4069e4d56e6a66 | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.53e-08 | 200 | 159 | 9 | c22cbfecee00183dd4be678f116ab9fd9ad0a4dd | |
| ToppCell | distal-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.53e-08 | 200 | 159 | 9 | 12b705dabec1b3752a488a891eda1a5123fcdc41 | |
| ToppCell | medial-2-mesenchymal-Alveolar_Fibroblast|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.53e-08 | 200 | 159 | 9 | cc6062dac07916c29091fc6bee2b864d29e6525b | |
| ToppCell | medial-mesenchymal-Alveolar_Fibroblast-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.53e-08 | 200 | 159 | 9 | 5c0716bf375c8158f7dc2c82bf5eaf37af594dd0 | |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-08 | 200 | 159 | 9 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-08 | 200 | 159 | 9 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-08 | 200 | 159 | 9 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| ToppCell | cellseq-Mesenchymal|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.53e-08 | 200 | 159 | 9 | 238285fc372ce2e5e4341fc3084a3a833bf4a0a6 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 4.53e-08 | 200 | 159 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-08 | 200 | 159 | 9 | 8c62f05c6042f24287a73fbdf80ff4a56f7ff403 | |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.53e-08 | 200 | 159 | 9 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_bronchial_vessel-D122|Adult / Lineage, Cell type, age group and donor | 1.84e-07 | 170 | 159 | 8 | a99cb3d21f8eb926886340ea99491e078e607648 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Fibroblasts-COL13A1+_matrix_FBs|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 2.40e-07 | 176 | 159 | 8 | 510f9a14dc1c151d24d079e0cc004cdf4f86336c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.50e-07 | 177 | 159 | 8 | b872ee91e01265b101b81bd304cf6b95d5419e68 | |
| ToppCell | Pericytes-Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-07 | 178 | 159 | 8 | a2448d868da2abe48c394c51264aad03e866dfec | |
| ToppCell | -Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.73e-07 | 179 | 159 | 8 | 10fadbaa1b6d21cbf9f354d717cc4c225619f4fd | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.84e-07 | 180 | 159 | 8 | 01f2e5d96016823482f89ba503d007d4bd88eeac | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-07 | 181 | 159 | 8 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.97e-07 | 181 | 159 | 8 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-07 | 182 | 159 | 8 | b7d532feb73167e05475855061b35a209583f44c | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.09e-07 | 182 | 159 | 8 | af65f0fc3f9e5d9ce69ee5faaf5b6cb7f8412e0c | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.50e-07 | 185 | 159 | 8 | 355b03c7ea438681e11a2b872c798c9ea26e1486 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.50e-07 | 185 | 159 | 8 | 90caab8d9361a541c5d5121c97c3f1cdffeeae4a | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.65e-07 | 186 | 159 | 8 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_lymph_vessel-D175|Adult / Lineage, Cell type, age group and donor | 3.80e-07 | 187 | 159 | 8 | 1e52d3d9d664c813d859b5b75e4c07b218818f95 | |
| Computational | Adhesion molecules. | 2.55e-06 | 141 | 90 | 9 | MODULE_122 | |
| Computational | Neighborhood of IGFBP1 | 1.09e-04 | 57 | 90 | 5 | CAR_IGFBP1 | |
| Drug | 4-Iodopyrazole | 3.28e-07 | 3 | 158 | 3 | DB02721 | |
| Drug | Fomepizole | 1.30e-06 | 4 | 158 | 3 | DB01213 | |
| Disease | Non-alcoholic Fatty Liver Disease | 1.82e-06 | 70 | 154 | 6 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 1.82e-06 | 70 | 154 | 6 | C3241937 | |
| Disease | mesangial proliferative glomerulonephritis (biomarker_via_orthology) | 7.66e-06 | 8 | 154 | 3 | DOID:4783 (biomarker_via_orthology) | |
| Disease | intraocular pressure measurement | TES SH2B3 FBXL17 PARD3B ADAMTS8 F2 ZNF469 ELMO3 FBN1 FBN2 ADAMTS6 | 7.92e-05 | 509 | 154 | 11 | EFO_0004695 |
| Disease | RENAL ADYSPLASIA | 8.09e-05 | 3 | 154 | 2 | C1619700 | |
| Disease | connective tissue disease (implicated_via_orthology) | 8.09e-05 | 3 | 154 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | Alcohol Use Disorder | 8.23e-05 | 44 | 154 | 4 | C0001956 | |
| Disease | bilirubin measurement | 1.16e-04 | 442 | 154 | 10 | EFO_0004570 | |
| Disease | diet measurement | DLGAP2 SH2B3 TRIO INSM1 LAMA2 XKR6 F2 LDLR ADH1C PHF1 ZNF469 CBLN4 DSTYK PCDHGB4 NR3C2 CPNE4 | 1.26e-04 | 1049 | 154 | 16 | EFO_0008111 |
| Disease | factor VIII measurement, Ischemic stroke | 1.27e-04 | 19 | 154 | 3 | EFO_0004630, HP_0002140 | |
| Disease | reticulocyte measurement | VWF SH2B3 SWAP70 ASH1L ACVR1C RREB1 LRCH1 ADH1B ZNF469 PROZ EGF RNH1 SYNE2 PCDHGB4 RORB TRIM40 | 1.32e-04 | 1053 | 154 | 16 | EFO_0010700 |
| Disease | scoliosis (is_implicated_in) | 1.61e-04 | 4 | 154 | 2 | DOID:0060249 (is_implicated_in) | |
| Disease | pheochromocytoma (implicated_via_orthology) | 1.61e-04 | 4 | 154 | 2 | DOID:0050771 (implicated_via_orthology) | |
| Disease | Endometrioma | 2.08e-04 | 161 | 154 | 6 | C0269102 | |
| Disease | Endometriosis | 2.08e-04 | 161 | 154 | 6 | C0014175 | |
| Disease | Liver Cirrhosis | 2.10e-04 | 103 | 154 | 5 | C0023890 | |
| Disease | isoleucine measurement | 2.12e-04 | 56 | 154 | 4 | EFO_0009793 | |
| Disease | level of Sphingomyelin (d40:2) in blood serum | 2.29e-04 | 23 | 154 | 3 | OBA_2045181 | |
| Disease | central corneal thickness | 2.30e-04 | 309 | 154 | 8 | EFO_0005213 | |
| Disease | Fibrosis, Liver | 2.30e-04 | 105 | 154 | 5 | C0239946 | |
| Disease | IGF-1 measurement | 2.57e-04 | 488 | 154 | 10 | EFO_0004627 | |
| Disease | Alcohol dependence | 2.68e-04 | 5 | 154 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 2.68e-04 | 5 | 154 | 2 | 103780 | |
| Disease | Congenital absence of kidneys syndrome | 2.68e-04 | 5 | 154 | 2 | C1609433 | |
| Disease | non-high density lipoprotein cholesterol measurement | CNKSR1 SH2B3 LAMC2 GC ACVR1C LDLR ADH1B IL1F10 DSTYK SYNE2 NR1H4 WDR72 | 3.81e-04 | 713 | 154 | 12 | EFO_0005689 |
| Disease | Congenital muscular dystrophy (disorder) | 4.00e-04 | 6 | 154 | 2 | C0699743 | |
| Disease | essential thrombocythemia (is_implicated_in) | 4.00e-04 | 6 | 154 | 2 | DOID:2224 (is_implicated_in) | |
| Disease | Subfertility, Female | 4.15e-04 | 28 | 154 | 3 | C0341869 | |
| Disease | Sterility, Postpartum | 4.15e-04 | 28 | 154 | 3 | C0038279 | |
| Disease | Female sterility | 4.15e-04 | 28 | 154 | 3 | C0917730 | |
| Disease | Female infertility | 4.15e-04 | 28 | 154 | 3 | C0021361 | |
| Disease | Alcohol abuse | 4.24e-04 | 67 | 154 | 4 | C0085762 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 5.10e-04 | 30 | 154 | 3 | EFO_0004629, HP_0002140 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 5.28e-04 | 71 | 154 | 4 | EFO_0007878, EFO_0007979 | |
| Disease | Akinetic Petit Mal | 5.59e-04 | 7 | 154 | 2 | C0001890 | |
| Disease | atherosclerosis (implicated_via_orthology) | 5.59e-04 | 7 | 154 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | Epilepsy, Absence, Atypical | 5.59e-04 | 7 | 154 | 2 | C0751124 | |
| Disease | Absence Seizure Disorder | 5.59e-04 | 7 | 154 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 5.59e-04 | 7 | 154 | 2 | C4317339 | |
| Disease | Childhood Absence Epilepsy | 5.59e-04 | 7 | 154 | 2 | C4281785 | |
| Disease | Epilepsy, Minor | 5.59e-04 | 7 | 154 | 2 | C4552765 | |
| Disease | Absence Epilepsy | 5.59e-04 | 7 | 154 | 2 | C0014553 | |
| Disease | hyperuricemia | 6.78e-04 | 33 | 154 | 3 | EFO_0009104 | |
| Disease | Unilateral agenesis of kidney | 7.42e-04 | 8 | 154 | 2 | C0266294 | |
| Disease | vitamin D measurement, vitamin D dietary intake measurement | 7.42e-04 | 8 | 154 | 2 | EFO_0004631, EFO_0008539 | |
| Disease | cortical thickness | TES LAMA2 ABCC9 ADAMTS8 XKR6 RREB1 LRCH1 STAB1 ZNF469 FBN1 FBN2 FBXL7 PI4KA PCDHGB4 ASTN2 | 7.51e-04 | 1113 | 154 | 15 | EFO_0004840 |
| Disease | Schizophrenia | DLGAP2 LAMA2 ITGA8 GC DBN1 F2 TRRAP GCLC PI4KA NR2E1 LRP2 ASTN2 SDHA | 7.67e-04 | 883 | 154 | 13 | C0036341 |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 9.51e-04 | 37 | 154 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | Developmental delay (disorder) | 9.51e-04 | 37 | 154 | 3 | C0424605 | |
| Disease | pulse pressure measurement | SWAP70 MYT1 FBXL17 ABCC9 ADAMTS8 RREB1 MEI1 CR1L LRCH1 SVEP1 ADH1B ADH1C ASAP2 FBN1 FBN2 FBXL7 SLIT1 | 9.98e-04 | 1392 | 154 | 17 | EFO_0005763 |
| Disease | reticulocyte count | VWF SH2B3 SWAP70 ASH1L ACVR1C RREB1 ADH1B ZNF469 EGF RNH1 DSTYK SYNE2 PCDHGB4 TRIM40 | 1.19e-03 | 1045 | 154 | 14 | EFO_0007986 |
| Disease | factor VIII measurement | 1.20e-03 | 40 | 154 | 3 | EFO_0004630 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 1.38e-03 | 42 | 154 | 3 | EFO_0004286, EFO_0004629 | |
| Disease | oral microbiome measurement | 1.38e-03 | 42 | 154 | 3 | EFO_0801229 | |
| Disease | hypertrophic cardiomyopathy | 1.40e-03 | 92 | 154 | 4 | EFO_0000538 | |
| Disease | late onset Parkinson's disease (is_implicated_in) | 1.44e-03 | 11 | 154 | 2 | DOID:0060892 (is_implicated_in) | |
| Disease | Posterior Choroidal Artery Infarction | 1.44e-03 | 11 | 154 | 2 | C0887799 | |
| Disease | Cerebral Infarction, Left Hemisphere | 1.44e-03 | 11 | 154 | 2 | C0751010 | |
| Disease | Anterior Choroidal Artery Infarction | 1.44e-03 | 11 | 154 | 2 | C0751012 | |
| Disease | Cerebral Infarction, Right Hemisphere | 1.44e-03 | 11 | 154 | 2 | C0751011 | |
| Disease | Subcortical Infarction | 1.44e-03 | 11 | 154 | 2 | C0751014 | |
| Disease | Cerebral Infarction | 1.44e-03 | 11 | 154 | 2 | C0007785 | |
| Disease | Neurodevelopmental Disorders | 1.45e-03 | 93 | 154 | 4 | C1535926 | |
| Disease | social interaction measurement | 1.51e-03 | 94 | 154 | 4 | EFO_0009592 | |
| Disease | Myocardial Infarction | 1.57e-03 | 95 | 154 | 4 | C0027051 | |
| Disease | retinal vasculature measurement | 1.64e-03 | 517 | 154 | 9 | EFO_0010554 | |
| Disease | C-reactive protein measurement | VWC2 TES FBXL17 DGKH XKR6 RREB1 ADH1B ADH1C ZNF469 IL1F10 KLHL7 DSTYK CPNE4 NR1H4 WDR72 | 1.67e-03 | 1206 | 154 | 15 | EFO_0004458 |
| Disease | Carcinoma, Neuroendocrine | 1.73e-03 | 12 | 154 | 2 | C0206695 | |
| Disease | cortical surface area measurement | TES MYT1 LAMA2 FBXL17 PARD3B XKR6 RREB1 LRCH1 SVEP1 ZNF469 FBN1 FBN2 FBXL7 DSTYK ASTN2 NR3C2 | 1.84e-03 | 1345 | 154 | 16 | EFO_0010736 |
| Disease | FEV/FEC ratio | ITGA8 FBXL17 LAMC2 MSL1 ACVR1C RREB1 MEI1 SPTBN5 PHF1 ASAP2 FBN1 KLHL7 SYNE2 ASTN2 MRTFA | 1.98e-03 | 1228 | 154 | 15 | EFO_0004713 |
| Disease | vitamin D measurement | 1.99e-03 | 336 | 154 | 7 | EFO_0004631 | |
| Disease | Cardiomyopathy, Dilated | 2.03e-03 | 48 | 154 | 3 | C0007193 | |
| Disease | Amyotrophic Lateral Sclerosis, Familial | 2.03e-03 | 48 | 154 | 3 | C4551993 | |
| Disease | Amyotrophic Lateral Sclerosis, Sporadic | 2.03e-03 | 48 | 154 | 3 | C1862941 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | liver cirrhosis (implicated_via_orthology) | 2.03e-03 | 13 | 154 | 2 | DOID:5082 (implicated_via_orthology) | |
| Disease | AMYOTROPHIC LATERAL SCLEROSIS 1 | 2.28e-03 | 50 | 154 | 3 | C1862939 | |
| Disease | Metabolic Bone Disorder | 2.36e-03 | 14 | 154 | 2 | C0005944 | |
| Disease | pulse pressure measurement, social deprivation | 2.36e-03 | 14 | 154 | 2 | EFO_0005763, EFO_0009696 | |
| Disease | Intellectual Disability | 2.49e-03 | 447 | 154 | 8 | C3714756 | |
| Disease | corneal topography | 2.60e-03 | 109 | 154 | 4 | EFO_0004345 | |
| Disease | corneal resistance factor | 2.63e-03 | 451 | 154 | 8 | EFO_0010067 | |
| Disease | blood urea nitrogen measurement | 2.66e-03 | 452 | 154 | 8 | EFO_0004741 | |
| Disease | Proteinuria | 2.72e-03 | 15 | 154 | 2 | HP_0000093 | |
| Disease | Osteopenia | 2.72e-03 | 15 | 154 | 2 | C0029453 | |
| Disease | triacylglycerol 46:0 measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0010400 | |
| Disease | Ischemic stroke, tissue plasminogen activator measurement | 2.72e-03 | 15 | 154 | 2 | EFO_0004791, HP_0002140 | |
| Disease | mean platelet volume | VWF PCDHGC4 PCDHGB5 STXBP5 LRCH1 SVEP1 PI4KA DSTYK SYNE2 PCDHGB4 NR3C2 TRIM40 MRTFA | 2.75e-03 | 1020 | 154 | 13 | EFO_0004584 |
| Disease | Acute Cerebrovascular Accidents | 2.85e-03 | 54 | 154 | 3 | C0751956 | |
| Disease | brain aneurysm | 2.96e-03 | 113 | 154 | 4 | EFO_0003870 | |
| Disease | alcohol dependence measurement | 3.00e-03 | 55 | 154 | 3 | EFO_0007835 | |
| Disease | amino acid measurement | 3.06e-03 | 678 | 154 | 10 | EFO_0005134 | |
| Disease | alcohol use disorder (is_implicated_in) | 3.10e-03 | 16 | 154 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | methylcobalamin deficiency type cblE, brain serotonin transporter measurement | 3.10e-03 | 16 | 154 | 2 | EFO_0004569, MONDO_0009354 | |
| Disease | antihyperlipidemic drug use measurement | 3.15e-03 | 115 | 154 | 4 | EFO_0803367 | |
| Disease | Carcinoma, Granular Cell | 3.25e-03 | 116 | 154 | 4 | C0205644 | |
| Disease | Adenocarcinoma, Tubular | 3.25e-03 | 116 | 154 | 4 | C0205645 | |
| Disease | Adenocarcinoma, Oxyphilic | 3.25e-03 | 116 | 154 | 4 | C0205642 | |
| Disease | Carcinoma, Cribriform | 3.25e-03 | 116 | 154 | 4 | C0205643 | |
| Disease | Adenocarcinoma, Basal Cell | 3.25e-03 | 116 | 154 | 4 | C0205641 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AETPEVLRECGCKGI | 6 | Q9NXW9 | |
| PDDDTRKGCVDDCLN | 2101 | Q9NR48 | |
| VAEKPLCSQCEAGRL | 1056 | Q9NY47 | |
| IDAASPLEKVCLIGC | 161 | P07327 | |
| VCDALAVPVRSGSCD | 451 | Q96BT7 | |
| CDPNKSCSVIEDEGL | 341 | Q9UP79 | |
| IDAASPLEKVCLIGC | 161 | P00325 | |
| IDAASPLEKVCLIGC | 161 | P00326 | |
| CELSIAGTPCRKSID | 441 | Q9Y3Q7 | |
| LAAAAELSPGLKCVC | 16 | Q8NER5 | |
| NVSCCELGIKPERVE | 41 | Q53H64 | |
| NDVKCSACEGLALTP | 346 | Q9P1A6 | |
| SSDGDLCLVVKEEPC | 211 | Q6PIY7 | |
| GSIRFNLDPECKCTD | 1401 | O60706 | |
| ASLPQECEKELASLC | 341 | Q17RM4 | |
| SGVEIRCEEKGRCPS | 971 | O75129 | |
| CEPERSCSINEDIGL | 381 | Q9UKP5 | |
| AGCCAKTTVAPLDRV | 46 | P16260 | |
| IKGDELCVVCGDRAS | 131 | Q96RI1 | |
| DREEICGKKPACALE | 91 | Q9UN71 | |
| TEEVPGSLCLRKFSC | 361 | Q6WBX8 | |
| RELKGEPDCCALSLE | 476 | Q8TEW8 | |
| RCLACVETEEGPSLQ | 66 | Q8WWZ1 | |
| SVARPEACIKCLGTA | 181 | Q96G91 | |
| EGEIARCKQLICDPS | 271 | P50395 | |
| CTPEDSALRCLLEGS | 806 | Q5VUB5 | |
| SLPRSCKEIKDECPS | 36 | Q8WWA0 | |
| LKSETCGCRIPVDFS | 131 | Q9NPJ1 | |
| ASIRSCLEEGLEPTC | 16 | P31513 | |
| CLEEGLEPTCFEKSN | 21 | P31513 | |
| EACGKATDPGRLLLC | 1011 | Q8NEZ4 | |
| SSRPSKICLVCGDEA | 596 | P08235 | |
| GARFLCSDEACPLSK | 146 | Q4G0Z9 | |
| CRVKCGPRLSAEAAE | 566 | P33992 | |
| KLDSEAVPRATCCPD | 946 | Q9P107 | |
| CVCRDDPDLGSAFLK | 86 | O43150 | |
| GACPAAEIKCLVIDE | 201 | Q8IYD8 | |
| TQACPESSCLREGEK | 76 | O94992 | |
| EELAIPKCCLEASTE | 541 | O75564 | |
| TIDGPSKVQLDCREC | 2541 | Q14315 | |
| LRDEEKSCPCLAQEG | 36 | P22749 | |
| ELCECPELLGSAFRK | 611 | P48506 | |
| CCPFVLDKDGVSAAV | 431 | Q96G03 | |
| DNICRCLKAGLTVDP | 571 | P42356 | |
| CLLGEPKIQACSRSE | 141 | P12525 | |
| EACRKLGVPEADLCS | 651 | Q9Y2L9 | |
| CDPIGSLNEVCVKDE | 416 | P24043 | |
| VLAECLDCPELKATA | 151 | Q8IXQ5 | |
| KDCSDGSDELALCPQ | 3536 | P98164 | |
| VGEDVPDARKCACAS | 86 | Q16643 | |
| DREEICGKKPACALE | 91 | Q9Y5G0 | |
| DREALCGLSASCIVP | 91 | Q9Y5F7 | |
| LEGNLPVSAKCAVCD | 251 | Q86XP1 | |
| KCGALSLELEPADCG | 626 | Q96MM6 | |
| EEPCGSLSETVCKRE | 366 | Q68DK7 | |
| CCVPETKGRSLEQIE | 481 | Q9UGQ3 | |
| ICSGSVKLPEAFERC | 841 | Q6XUX3 | |
| CGEDNLCVPDLKLSA | 641 | P53708 | |
| KEGLETAISCPDAAC | 56 | P50876 | |
| KDPLLSQACVGCLEA | 1116 | Q5TIA1 | |
| SLPQKICLICGDEAS | 561 | P06401 | |
| SCPRVDTVDCDGLDL | 51 | Q6PEZ8 | |
| NATLAVEKEGCPVCI | 31 | Q6NT52 | |
| VPRCDLVDLGEGKIC | 36 | Q15884 | |
| DAPGSCLIDCNEKTR | 106 | P63145 | |
| PCSIRESGLETVAKC | 261 | Q8TED4 | |
| DAPGSCIIDCNEKTR | 106 | P62684 | |
| GTVCDPARSCAIVED | 336 | O75173 | |
| CPCGDNFSITKEELE | 26 | Q9H4G8 | |
| LDSPCGESLECVRGL | 66 | P83110 | |
| EPIVLEGKCLVVCDS | 26 | P23435 | |
| CFCPEGSVLERDGKT | 421 | P01133 | |
| CIKDYERLSCIGSPI | 86 | Q9UKT4 | |
| KCPLVSDTGLECLAL | 411 | Q9UJT9 | |
| GKACEDIDECSLPNI | 1441 | P35555 | |
| AKQLGELCTERDPCD | 61 | P29279 | |
| RSPLNCDPEKEASCV | 206 | Q6ZNA5 | |
| SPASCCKELGLAAAA | 136 | Q9UF56 | |
| AAPRCEVKSCDDFLG | 341 | Q2VPA4 | |
| SLCSGDPDRRLKCIV | 216 | Q96A23 | |
| GKRCELSAECPSLTD | 36 | P26998 | |
| LEGKCLVVCDSNPAT | 36 | Q9NTU7 | |
| EPIVLEGKCLVVCDS | 56 | Q8IUK8 | |
| SKREEILAGFPCCRS | 151 | Q5JW98 | |
| DRELCSGPSKLCQAL | 211 | P29372 | |
| LCELLRVGEPCSETA | 411 | Q96BJ8 | |
| IIDCSGKCILPGLVD | 71 | Q96NU7 | |
| RSCPSCGSELGVEEK | 16 | O75426 | |
| NPLEEEGLCCRDVTS | 306 | Q6ZW76 | |
| ACPSEEDESLKGCEL | 6 | P31321 | |
| DQRLLDSKCDCDPAG | 131 | Q13753 | |
| EGEVARCKQLICDPS | 271 | P31150 | |
| IDECRISPDLCGSGI | 1116 | P35556 | |
| SKCVVRVEECRGPTD | 106 | Q9HBV2 | |
| EESIRKCQGSSDLPC | 321 | O95965 | |
| DCAACGERPTVTDLL | 296 | O95396 | |
| KCLREEQETGICGSP | 76 | W6CW81 | |
| ILDIPCKVCGDRSSG | 11 | Q9Y466 | |
| RGLDELDGVKAACPC | 1976 | Q5THK1 | |
| CEIPAVLKLACADTS | 176 | Q8NH01 | |
| ARPLGEFICQLCKEE | 261 | Q01101 | |
| CLECDPKFIEDVGSL | 21 | Q5VZ72 | |
| ARLPACALSCEASKE | 771 | Q6ZRI0 | |
| ECVKAPVCLSRELGV | 2681 | Q6ZRI0 | |
| GCSEKLEDLLCFQTP | 221 | P00540 | |
| ETVVPGNRLVSCEKC | 96 | O43189 | |
| DLEELCPVCGDKVSG | 81 | O00482 | |
| EGVCPICQESLKEAV | 11 | Q6P9F5 | |
| SEKPRCAGCDELIFS | 296 | Q9UGI8 | |
| GLCPSVAEIIEEKCQ | 5346 | Q8WXH0 | |
| ACALSIEESCRPGDK | 466 | P31040 | |
| CACGVLTSEKRAPDL | 171 | P22891 | |
| LLAAEDQVPCEKCGS | 626 | Q9Y253 | |
| VALFTLICCPGSDEK | 11 | P13598 | |
| LCDISEGTVVPEDRC | 696 | Q5T5C0 | |
| IDSKSIFCSDCPRLG | 1621 | Q4LDE5 | |
| ILVKEEGPRAGSCCL | 496 | Q969V6 | |
| LNECTTKDARPGCLL | 3656 | Q9NRC6 | |
| AEACREPACAEGSVK | 211 | Q7Z7C7 | |
| PADLVLEEGDCVRKC | 171 | O43916 | |
| GAISSEAVCKPLCAR | 141 | Q9GZX3 | |
| EVGLVEDTACERSCP | 216 | Q9NS84 | |
| LRAGKCAELPNCLDD | 251 | Q86T13 | |
| LGDCAKTPIDVLCAA | 101 | Q969H4 | |
| ILTLDPSEGEVCCKK | 76 | Q9BTD1 | |
| ILCEPSVKSLCEGLE | 346 | P37287 | |
| LADCEKEACSPVSEG | 456 | Q8TBB6 | |
| TGPRAKILASSCCAE | 501 | Q5GH73 | |
| IPAGREVKTDECTIC | 286 | Q2TAL6 | |
| SCPRADVTLEEKGCA | 86 | Q96SZ4 | |
| CPADNLRAEGLECTK | 776 | P04275 | |
| RLCEDIDAEPSSTGC | 146 | Q7Z6I5 | |
| EDSGCAALGDCKPLT | 846 | Q92766 | |
| LEDPGEARACCEKAL | 296 | Q969T3 | |
| EPCGTDCFLLLEGAK | 331 | Q92800 | |
| DATAQIEVIPCKICG | 11 | Q92753 | |
| CGCAAAPDVKELLSR | 111 | P24821 | |
| EYIPSLDKLICGCED | 411 | Q3MJ13 | |
| EPTLKSLGECCDVED | 366 | P02774 | |
| KDFLQGICLTPDCEG | 706 | P53804 | |
| DSPCQLEALKLESCG | 196 | P13489 | |
| IPLECGAACDVRLSS | 446 | Q9UQQ2 | |
| SGDGIRTCELLDPCS | 1531 | Q9NY15 | |
| LPCDICKDVVTAAGD | 61 | P07602 | |
| TVDSLVNKECCPRLG | 31 | P40126 | |
| SISPLKELVCAGECL | 91 | Q6X4U4 | |
| ENCPKGAETLVTRCL | 846 | Q92797 | |
| EEAGCPLSCAVSKRR | 511 | P07949 | |
| CDPKEALAGCLLQGE | 2176 | Q96JG9 | |
| EIAPELSEKISCKCD | 126 | Q5TYW1 | |
| KCEDCGKPLSIEADD | 536 | Q15942 | |
| PRDKLAACLEGNCAE | 96 | P00734 | |
| LDENCCVESLPDKDG | 256 | Q9UH65 | |
| GPACCRVLSELSEEQ | 291 | Q15633 | |
| DVLDGDEKPTCCRCR | 466 | O75604 | |
| EGKACEQLVDLCSPD | 1036 | O75093 | |
| KDALGCCVVQEEASP | 21 | Q6WRX3 | |
| NLCEAEDSALTKLPC | 1341 | Q9Y4A5 | |
| DCARSLEAVPKKLCG | 36 | Q9BYX2 | |
| LACIPSEEVCKRGFT | 111 | O75962 | |
| CKELGSSGLDCQPLE | 171 | P17097 | |
| EGEKSVECLRESPCG | 181 | Q8NAP8 | |
| VLCPCADAGSDSTKR | 1101 | P41229 | |
| SDEPIKECGTNECLD | 306 | P01130 | |
| ALKAEQVRTVCEPGC | 386 | Q01538 |